James C. Blair, Ph.D.

James C. Blair, Ph.D. has served as a member of our board of directors since August 2006. Dr. Blair has been a Partner of Domain Associates since its founding in 1985. His present board memberships include Cadence Pharmaceuticals, Cell Biosciences, Five Prime Therapeutics, GenVault, NeuroPace, Novacea and Pharmion. Dr. Blair has been involved in the creation and has served as a director of over 40 life sciences ventures, including Amgen, Aurora Biosciences, Amylin Pharmaceuticals, Applied Biosystems, Dura Pharmaceuticals, GeneOhm Sciences and Molecular Dynamics. A former Managing Director of Rothschild Inc., Dr. Blair was directly involved at a senior level with Rothschild/New Court venture capital activities from 1978 to 1985. From 1969 to 1978, he was associated with F.S. Smithers and Co. and White, Weld and Co., two investment banking firms actively involved with new ventures and emerging growth companies. From 1961 to 1969, Dr. Blair was Engineering Manager with RCA Corporation, during which time he received a David Sarnoff Fellowship. He currently serves on the board of directors of the Prostate Cancer Foundation, and he is on the advisory boards of the Department of Molecular Biology at Princeton University, the Department of Biomedical Engineering at the University of Pennsylvania and is a member of the board of counselors the University of Southern California Stevens Institute for Innovation. Dr. Blair received his B.S.E. from Princeton University, and his M.S.E. and Ph.D. from the University of Pennsylvania.